We are live on ! Find out more
HSCSW icon

HeartSciences Inc Warrant
HSCSW

3 hedge funds and large institutions have $176 invested in HeartSciences Inc Warrant in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+3
Holders Change %
–
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$163K
2
CS
Clear Street
New York
+$231

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$176 +$163K +352,941 New
CS
2
Clear Street
New York
– +$231 +500 New

HSCSW Hedge Fund Activity: Q2 2022 in Review

3 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in HeartSciences Inc Warrant (HSCSW) for Q2 2022, worth a combined $176.

Buyers outnumbered sellers: 3 funds opened new HSCSW positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $163K.

  • 3 institutional investors held HeartSciences Inc Warrant (HSCSW) as of Q2 2022, up from 0 in Q1 2022.
  • Funds reported $176 of HeartSciences Inc Warrant stock for Q2 2022.
  • 3 funds opened new HeartSciences Inc Warrant positions in Q2 2022 and 0 closed out, a net change of +3 holders.
  • The largest HeartSciences Inc Warrant buyer in Q2 2022 was Armistice Capital, an estimated $163K added.

Based on aggregated 13F filings for Q2 2022.